Heartbeam (BEAT)

• Market cap: $51.1M
• 1 day: -1.31%
• 5 days: -8.48%
• 1 month: -11.70%
• 3 months: -25.25%
• 6 months: -51.60%
• Year to date: -35.74%
• 1 year: -25.98%
• 5 years: -67.80%
• 10 years: -67.80%
• Sector: Healthcare
• Industry: Health Information Services

About: HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Employees: 19

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

6% more funds holding

Funds holding: 33 [Q4 2024] → 35 (+2) [Q1 2025]

0% more capital invested

Capital invested by funds: $6.09M [Q4 2024] → $6.11M (+$17.9K) [Q1 2025]

0.92% less ownership

Funds ownership: 9.93% [Q4 2024] → 9.01% (-0.92%) [Q1 2025]